Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Thermo Fisher Scientific Inc.: A Promising Future Ahead, According to Jim Cramer

January 01, 2025
Renowned stock market analyst Jim Cramer predicts a gradual improvement for Thermo Fisher Scientific Inc. (NYSE: TMO) in the coming years. With business picking up in 2025 and 2026, Cramer believes that the company's prospects are looking bright. Thermo Fisher Scientific, a leading global provider of scientific research tools and services, is well-positioned to capitalize on the growing demand for advanced scientific solutions. As industries such as pharmaceuticals, biotechnology, and healthcare continue to expand, Thermo Fisher's innovative products are expected to play a vital role in driving scientific progress. Investors are advised to consider the long-term potential of Thermo Fisher Scientific, and professionals from Stocks Prognosis can provide valuable insights regarding the company's stock movement.
If you want to leave a comment, then you need Login or Register





Other data for TMO

Related data

TMOAugust 30, 2025Thermo Fisher Scientific's New Sustainable Facility: a Game Changer for Long-Term Revenue Growth?  ~1 min.

Thermo Fisher Scientific Inc. recently announced the opening of its new sustainable facility, showcasing its commitment to environmental responsibility and innovation....


TMOAugust 19, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with Profit of 10.99%  ~1 min.

Thermo Fisher Scientific Inc. has successfully achieved the price target forecast set by QuantWave, signaling a profitable long position for investors....


TMOAugust 19, 2025Thermo Fisher Scientific Inc. Stock Hits Forecast Price Target with an 8.15% Profit  ~1 min.

Thermo Fisher Scientific Inc. (TMO) successfully reached its forecast price target as predicted by QuantWave on August 8, 2025. The forecast signal indicated a long position at a price of $460....


TMOJuly 24, 2025Thermo Fisher Scientific Inc. Stock Hits Forecasted Target Successfully, Generating 12.27% Profit  ~2 min.

On May 2, 2025, QuantWave, the automated forecasting platform, issued a long signal for Thermo Fisher Scientific Inc. with a price target of $475.03. The stock, which was trading at $423....


TMOJuly 23, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast, Generating Profit of 9.73%  ~2 min.

Thermo Fisher Scientific Inc. (TMO) has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 9.73%....


TMOJuly 23, 2025Thermo Fisher Scientific Inc. Achieves Price Target Forecast with 12.11% Profit  ~1 min.

Thermo Fisher Scientific Inc. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 12.11%....


TMOJuly 23, 2025Thermo Fisher Scientific Inc. Stock Hits Price Target with 9.82% Profit - QuantWave Forecast Success  ~1 min.

Thermo Fisher Scientific Inc. (TMO) stock achieved its price target forecast as predicted by QuantWave, generating a profit of 9.82% for investors....


TMOJuly 23, 2025Thermo Fisher Scientific Inc. Hits Price Target with 12.53% Profit, Validating QuantWave's Accuracy  ~1 min.

Thermo Fisher Scientific Inc. has successfully reached its price target forecast as predicted by QuantWave's analytics, delivering a substantial profit of 12.53% for investors....


TMOJuly 11, 2025Thermo Fisher Scientific Inc. Hits Price Target Forecast with 7.97% Profit  ~2 min.

Thermo Fisher Scientific Inc. has successfully reached the price target forecast set by QuantWave on 2025-06-13, signaling a long position at a price of 402.76 $....


TMOJuly 2, 2025Thermo Fisher Scientific Inc. Hit Price Target Forecast with 9.61% Profit, QuantWave Analysis Shows Strong Predictive Power  ~1 min.

Thermo Fisher Scientific Inc. (NYSE: TMO) recently reached a price target forecast set by QuantWave, an automated forecasting platform, with a profit of 9.61%....


REGNJanuary 4, 2025Regeneron Pharmaceuticals Inc.: A Strong Investment Opportunity for Shareholders  ~1 min.

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) has proven to be a successful investment option for shareholders, with a decent 89% return over the last five years....


REGNFebruary 9, 2025Regeneron Pharmaceuticals Inc REGN Reports Strong Earnings in Q4 2024  ~2 min.

Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....


REGNJanuary 2, 2025Regeneron Pharmaceuticals: Discoveries and Innovations Driving Growth  ~2 min.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been making significant strides in the pharmaceutical industry, driving growth and attracting investors....


VRTXJanuary 6, 2025Investors Should Consider Buying Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Now  ~2 min.

Vertex Pharmaceuticals Incorporated is a leading biotechnology company specializing in the discovery, development, and commercialization of innovative medicines for serious diseases....


VRTXFebruary 13, 2025Vertex Pharmaceuticals Announces Impressive Q4 2024 Earnings and FDA Approval of Key Drugs  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX), a leading biotechnology company, has reported its strong financial results for the fourth quarter and full year of 2024....